Clinical Topics & News

Nodular Fasciitis: A Possible Side Effect of Etanercept?

Etanercept is a biologic agent prescribed by dermatologists for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis. Although the safety profile of etanercept is well established, it is always important to be vigilant in noting the development of novel side effects associated with biologic agents. We report a case of biopsy-proven nodular fasciitis (NF) that developed in an otherwise healthy man with plaque psoriasis who was undergoing treatment with etanercept.


 

Recommended Reading

Methotrexate Toxicity Induced by Ciprofloxacin Leading to Psoriatic Plaque Ulceration: A Case Report
Psoriasis Collection
Psoriasiform Eruption Associated With Graft-Versus-Host Disease
Psoriasis Collection
Product News: 09 2013
Psoriasis Collection
Psoriasis and Leprosy: A Mystifying Coexistence
Psoriasis Collection
Psoriasis linked to increased heart failure risk
Psoriasis Collection
Ustekinumab approved for psoriatic arthritis
Psoriasis Collection
Limited data support multiple myositis treatment options
Psoriasis Collection
Autoantibodies play role in myositis classification, treatment
Psoriasis Collection
Psoriasis Treatment With Tumor Necrosis Factor Inhibitors
Psoriasis Collection
Palmar-plantar psoriasis? Anti-TNF therapy may be culprit
Psoriasis Collection

Related Articles